Delanoy, N, Hardy-Bessard, A-C, Efstathiou, E, Le Moulec, S, Basso, U, Birtle, A, Thomson, A, Krainer, M, Guillot, A, De Giorgi, U, Hasbini, A
, Daugaard, G, Bahl, A, Chowdhury, S, Caffo, O, Beuzeboc, P, Spaeth, D, Eymard, J-C, Fléchon, A, Alexandre, J, Helissey, C, Butt, M, Priou, F, Lechevallier, E, Deville, J-L, Gross-Goupil, M, Morales, R, Thiery-Vuillemin, A, Gavrikova, T, Barthélémy, P, Sella, A, Fizazi, K, Ferrero, J-M, Laguerre, B, Thibault, C, Hans, S & Oudard, S 2020,
Corrigendum to "Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database" [Eur J Canc 125, (January 2020) 153-163]..
https://doi.org/10.1016/j.ejca.2020.05.006